Residency · Residency · Infectiousdisease

Skin and Soft Tissue Infections - Necrotizing Fasciitis

Classification of Skin and Soft Tissue Infections

Anatomic Depth

Skin and soft tissue infections span a broad spectrum of severity defined primarily by the anatomic depth of involvement. Superficial infections include impetigo, which is confined to the epidermis, erysipelas, which involves the upper dermis and lymphatics and presents with sharply demarcated raised erythematous borders, and folliculitis, which involves hair follicles. Uncomplicated skin and soft tissue infections encompass cellulitis, involving the dermis and subcutaneous tissue, and simple abscesses. Complicated skin and soft tissue infections, termed cSSSI or acute bacterial skin and skin structure infections (ABSSSI) in regulatory terminology, involve deeper tissue, carry significant comorbidity, or require surgical intervention or intravenous antibiotics. At the far end of the severity spectrum lie necrotizing soft tissue infections, which involve fascial necrosis with or without myonecrosis and constitute surgical emergencies with mortality rates that climb dramatically with each hour of delayed intervention.

FDA ABSSSI Definition

The FDA defines ABSSSI for clinical trial enrollment as wound infection, cellulitis, or major abscess with a minimum erythema area of 75 square centimeters, roughly the area larger than a standard index card. This definition serves an important regulatory function in establishing enrollment criteria for registration trials of new antibiotics but should not be conflated with clinical severity classification.

Cellulitis

Clinical Features and Diagnosis

Cellulitis presents as unilateral erythema, warmth, edema, and tenderness with poorly demarcated borders, distinguishing it from erysipelas, which characteristically produces sharply demarcated, raised borders reflecting its more superficial location within the dermis and lymphatics. The most common misdiagnosis of cellulitis is venous stasis dermatitis, which is characteristically bilateral. Other common mimics include contact dermatitis, deep vein thrombosis, and gout, and collectively these "pseudo-cellulitis" diagnoses account for approximately 30 percent of hospital admissions attributed to cellulitis. Blood cultures are positive in fewer than 5 percent of cases of uncomplicated cellulitis and are not routinely recommended. Surface swabs have no diagnostic utility; wound cultures or aspirate cultures should only be obtained when purulent drainage is present.

Microbiology

A critical clinical teaching point is the distinction between non-purulent and purulent cellulitis, as the microbiology differs substantially. Non-purulent cellulitis is caused by beta-hemolytic streptococci in the vast majority of cases, with Group A Streptococcus being more common than Groups B, C, and G, and S. aureus contributing less frequently than traditionally taught. Purulent cellulitis and abscesses, in contrast, are predominantly caused by S. aureus, with MRSA accounting for 50 to 75 percent of community-acquired abscesses in the United States. Risk factors for MRSA include prior MRSA infection or colonization, injection drug use, homelessness, incarceration, contact sports participation, and recurrent abscesses.

Treatment - Non-Purulent Cellulitis

Mild non-purulent cellulitis is treated with oral cephalexin 500 milligrams four times daily, dicloxacillin 500 milligrams four times daily, or clindamycin 300 to 450 milligrams three times daily for five to seven days. Moderate disease warrants intravenous cefazolin 2 grams every 8 hours or nafcillin 2 grams every 4 hours, with transition to oral therapy when clinical improvement occurs. MRSA coverage is not routinely needed for non-purulent cellulitis, as streptococcal etiology predominates. Adjunctive measures include leg elevation, compression therapy for lower extremity cellulitis, and treatment of underlying tinea pedis, which frequently serves as the portal of entry for recurrent lower extremity cellulitis. Marking the borders of erythema with a pen provides a practical method for monitoring progression or resolution.

Treatment - Purulent Cellulitis/Abscess

Incision and drainage is the primary treatment for abscesses. For small abscesses less than 2 centimeters, incision and drainage alone may suffice per IDSA guidelines. For larger abscesses, incision and drainage should be supplemented with antibiotics, with trimethoprim-sulfamethoxazole double-strength one to two tablets twice daily or doxycycline 100 milligrams twice daily for five to seven days providing effective MRSA coverage. The IDSA 2014 guidelines, supported by subsequent randomized trials, established that antibiotics in addition to incision and drainage improve cure rates for abscesses.

Necrotizing Soft Tissue Infections (NSTI)

Classification

Necrotizing soft tissue infections are classified into three types based on their microbiology. Type I, the polymicrobial or synergistic form, accounts for 70 to 80 percent of cases and involves mixed aerobic and anaerobic flora including streptococci, Enterobacterales, Bacteroides, Clostridium, and Peptostreptococcus. Risk factors for type I NSTI include diabetes, peripheral vascular disease, post-surgical status, perianal or perineal location such as Fournier gangrene, and chronic liver disease.

Type II NSTI is monomicrobial and accounts for 20 to 30 percent of cases. Group A Streptococcus is the most feared cause, associated with streptococcal toxic shock syndrome and mortality rates of 30 to 70 percent. S. aureus, including community-associated MRSA, is another important monomicrobial cause. Environmental exposures create risk for specific pathogens: Vibrio vulnificus follows saltwater or raw shellfish exposure and is particularly lethal in patients with cirrhosis and iron overload, presenting with rapidly progressive hemorrhagic bullae; Aeromonas hydrophila is associated with freshwater exposure; and Clostridium perfringens causes gas gangrene or myonecrosis following traumatic wounds, with rapid progression and crepitus. Type III NSTI represents gas gangrene or clostridial myonecrosis specifically.

Pathophysiology

The pathophysiology of necrotizing fasciitis reflects the unique vulnerability of the fascial plane, which has a limited blood supply that results in poor antibiotic penetration once infection has become established. As infection tracks along these fascial planes, thrombosis of perforating blood vessels produces tissue ischemia, which drives progressive necrosis in a self-amplifying cycle. Group A Streptococcus produces a potent array of virulence factors including superantigens such as SpeA and SpeB, M-protein, and streptolysin, which together trigger a massive cytokine release that can culminate in streptococcal toxic shock syndrome. Clostridium perfringens produces alpha-toxin, a lecithinase that causes myonecrosis, along with gas production, generating carbon dioxide and hydrogen within the tissues that manifest clinically as crepitus.

Clinical Diagnosis -- "Hard Signs" and "Soft Signs"

The clinical diagnosis of NSTI rests on recognizing both hard and soft signs. Hard signs, which carry specificity exceeding 90 percent, include crepitus, hemorrhagic bullae, skin necrosis or ecchymosis, gas on imaging, anesthesia of the involved skin indicating nerve destruction, and frank pus along fascial planes encountered at surgery. Soft signs have lower specificity but are critically important for early diagnosis: pain out of proportion to examination findings is the most important early clue and must trigger urgent surgical evaluation. Other soft signs include rapid progression despite appropriate antibiotics, systemic toxicity manifesting as tachycardia, hypotension, and high fever, and edema that extends beyond the visible area of erythema.

LRINEC Score

The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score incorporates CRP at 150 or above (4 points), white blood cell count above 25,000 (2 points) or 15,000 to 25,000 (1 point), hemoglobin below 11 (2 points) or 11 to 13.5 (1 point), sodium below 135 (2 points), creatinine above 1.6 (2 points), and glucose above 180 (1 point). A score of 6 or above is suggestive with a positive predictive value of approximately 92 percent, and a score of 8 or above is highly suggestive. However, the LRINEC score has significant limitations, with a sensitivity of only 50 to 70 percent, and must not be used to rule out NSTI or to delay surgical consultation. Clinical gestalt and the threshold for surgical exploration must remain paramount.

<image>A clinical photography-style illustration showing the progression of necrotizing fasciitis in four stages. Stage 1: "Early" showing tense edema with erythema and pain out of proportion to visible findings, with annotation "pain out of proportion is the key early clue." Stage 2: "Intermediate" showing dusky discoloration with hemorrhagic bullae forming. Stage 3: "Advanced" showing frank skin necrosis with ecchymotic patches and crepitus areas marked. Stage 4: "Intraoperative" showing dishwater-gray necrotic fascia with loss of tissue planes during surgical exploration, with the surgeon's finger easily dissecting along the fascial plane ("positive finger test"). Include anatomic cross-sections next to each stage showing the depth of infection progression from subcutaneous tissue through fascia. Use a medical illustration style appropriate for a surgical textbook.</image>

Imaging

CT with contrast is the most useful emergent imaging modality for suspected NSTI, with findings including fascial thickening and enhancement, gas tracking along fascial planes, fluid collections, and fat stranding. MRI is the most sensitive imaging modality but is time-consuming and should not delay surgery. Point-of-care ultrasound may demonstrate fascial thickening greater than 4 millimeters, subcutaneous air, and the cobblestoning pattern of subcutaneous edema. Plain radiography may show subcutaneous gas, a finding that is highly specific but insensitive, as gas is present in fewer than 25 percent of cases. The overriding principle is that imaging should never delay surgical exploration when clinical suspicion for NSTI is high.

Surgical Management -- The Definitive Treatment

Emergent surgical debridement is the single most important intervention in the management of necrotizing fasciitis. Time to surgery is the most critical prognostic variable, with every hour of delay increasing mortality and mortality approximately doubling when surgery is delayed beyond 12 to 24 hours. The surgical principle is to debride all necrotic tissue until viable, bleeding tissue is encountered. Planned re-exploration, the so-called second look operation, should be performed within 24 to 48 hours, and most patients require two to four debridements before the extent of necrosis is fully controlled. Fournier gangrene requires aggressive debridement of the perineum and scrotum, with diverting colostomy considered when rectal involvement is present. Amputation may be necessary for extremity NSTI with extensive involvement.

Antibiotic Therapy

Empiric antibiotic therapy for suspected NSTI should be broad-spectrum, consisting of vancomycin plus piperacillin-tazobactam or meropenem plus clindamycin. The inclusion of clindamycin is specifically for its ability to suppress toxin production, including Group A Streptococcus exotoxins and Clostridium perfringens alpha-toxin, and its activity is independent of inoculum size and unaffected by the Eagle effect. The Eagle effect describes the phenomenon whereby at high bacterial densities, beta-lactams are less effective against Group A Streptococcus because the organisms have entered stationary phase and are no longer actively dividing, whereas clindamycin, as a protein synthesis inhibitor, retains full activity regardless of growth phase. De-escalation is performed after culture data and surgical findings are available.

Organism-Specific Therapy

Group A Streptococcus NSTI is treated with penicillin G plus clindamycin, with the addition of intravenous immunoglobulin at a dose of 1 to 2 grams per kilogram for streptococcal toxic shock syndrome, based on observational data suggesting a mortality benefit. Clostridial gas gangrene is treated with penicillin G plus clindamycin; hyperbaric oxygen therapy is controversial and should never delay surgical intervention. Vibrio vulnificus infection is treated with doxycycline plus ceftriaxone or cefotaxime. Polymicrobial type I infections are managed with broad-spectrum coverage as described above, with narrowing based on intraoperative culture results.

<image>A treatment algorithm for suspected necrotizing fasciitis. Start with "Clinical suspicion of NSTI (pain out of proportion, systemic toxicity, rapid progression)." Immediate parallel actions: "1. SURGICAL CONSULTATION - EMERGENT (do not delay for imaging)" in a large red box, "2. Empiric antibiotics: vancomycin + pip-tazo (or meropenem) + clindamycin," "3. Resuscitation (IV fluids, vasopressors as needed, ICU admission)." If diagnosis uncertain, "CT with contrast (should not delay OR if high suspicion)." Post-surgery pathway: "Obtain tissue cultures, send to pathology (frozen section if available)." Decision branch for GAS/STSS: "Add IVIG 1-2 g/kg if streptococcal toxic shock syndrome." Bottom timeline: "Planned re-exploration in 24-48 hours until no further necrosis." Include mortality data: "Mortality with surgery <24h: 25-30%, Mortality with delayed surgery: 50-70%." Use red and yellow warning colors throughout to emphasize urgency.</image>

Special Entities

Fournier Gangrene

Fournier gangrene is a necrotizing soft tissue infection of the perineum, scrotum, or vulva that is typically polymicrobial. The source of infection is anorectal in 30 to 50 percent of cases, urogenital in 20 to 40 percent, and cutaneous in the remainder. Diabetes is present in 60 to 70 percent of patients, with alcoholism and immunosuppression as additional risk factors. Mortality remains high at 20 to 40 percent even with surgical intervention, and delays in surgery are associated with dramatically higher mortality. Management consists of aggressive surgical debridement, broad-spectrum antibiotics, wound vacuum-assisted closure therapy, and eventually reconstructive surgery.

Clostridial Myonecrosis (Gas Gangrene)

Clostridium perfringens is the causative organism in 80 to 95 percent of gas gangrene cases. C. septicum, while less common, is critically important because of its association with underlying malignancy, particularly colon cancer, and every patient with C. septicum gas gangrene should be screened for occult malignancy. The incubation period is typically less than 24 hours, and the clinical course is characterized by rapidly progressive pain, tense edema, bronze discoloration of the skin, and crepitus. A characteristic sweetish odor may be present, along with thin, serosanguinous discharge. Gram stain reveals large gram-positive rods with spores and a notable absence of polymorphonuclear cells, reflecting leukocyte destruction by the clostridial toxins. Spontaneous, non-traumatic gas gangrene caused by C. septicum should always prompt evaluation for occult malignancy.

Pyomyositis

Pyomyositis is a primary infection of skeletal muscle, typically caused by S. aureus in approximately 90 percent of cases in tropical regions and 60 to 70 percent in temperate climates. In temperate climates, pyomyositis is associated with immunosuppression, injection drug use, and HIV infection. Diagnosis is made by MRI demonstrating an intramuscular abscess, which can then be confirmed and treated by CT-guided aspiration. Treatment requires drainage plus antistaphylococcal antibiotics for two to four weeks.

Key Clinical Pearls

• Pain out of proportion to exam findings is the most important early clinical clue for necrotizing fasciitis -- it should trigger immediate surgical consultation
• Imaging should NEVER delay surgical exploration when clinical suspicion for NSTI is high
• Clindamycin is added to the NSTI regimen for toxin suppression (Eagle effect and superantigen inhibition), not for spectrum
• The LRINEC score should not be used to rule out NSTI -- low sensitivity means a low score does NOT exclude the diagnosis
• For non-purulent cellulitis, MRSA coverage is generally unnecessary -- beta-hemolytic streptococci are the predominant cause
• C. septicum gas gangrene without trauma is associated with underlying colon cancer -- always investigate
• Every hour of delay in surgical debridement for NSTI increases mortality -- time to surgery is the most critical prognostic factor

References

1. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the IDSA. Clin Infect Dis. 2014;59(2):e10-e52.
2. Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017;377(23):2253-2265.
3. Wong CH, Khin LW, Heng KS, et al. The LRINEC score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535-1541.
4. Sartelli M, Guirao X, Hardcastle TC, et al. 2018 WSES/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13:58.
5. Talan DA, Mower WR, Krishnadasan A, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med. 2016;374(9):823-832.

Read this lecture as Markdown